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Abstract
In May of 2004, the Tennessee General Assembly passed the Medication Error Reduction
Act of 2004 (MERA), which amended Title 63 of the Tennessee Code Annotated and as of July 1,
2004, defined several new criteria with which all written and electronic prescriptions must comply.
The following research demonstrates that a majority of phannacists are aware of the 11ERA
legislation, but believe that a considerable number of prescriptions still do not comply with the new
criteria. Additionally, an independent analysis of prescriptions showed that the majority of received
orders were in fact noncompliant with l\.1ERA legislation.
Though they bear a significant fraction of the responsibility for medications-related errors,
phannacists can do little to ensure that prescriptions comply with the legislation. Phannacists can
only correct or modify noncompliant prescriptions with approval of the authorized prescriber. As a
consequence, the Act is only effective if prescribers are enforcably held accountable for written and
electronic prescriptions. The Tennessee General Assembly has introduced legislation for the Spring
2005 session to revise l\.1ERA with the input of the Board of Medical Examiners. As evidenced by
this research, such revisions are necessary and would allow physicians and phannacists to share a
more equal responsibility for the reduction of medication-related errors, thus promoting better
health and safety for Tennessee patients.

Keywords: Medication Error Reduction Act (MERA), legibility law, prescription legibility,
medication errors, phannacy, phannacist sUlVey
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Introduction

.

.

.

Medications-related errors first came to the forefront of the healthcare mdustry Wlth a senes
of reports published by the Institute of Medicine. The firs~ report of this se~es, To E.rr is HU1'ltln
(Kohn, Corrigan, Donaldson) addressed the overall quality of healthcare m Amenca and the
consequences of preventable errors on patient health. Since the publication of this startling report
in 2000, medications-related errors have increasingly become the subject of lawsuits and news
headlines. To reduce and prevent these errors, many states have enacted new standards for the
transmission of patient medical infonnation, such as written and electronic prescriptions.
As described in the Fall 2004 issue of Terrn!Ssee Phann:teist, the Tennessee General Assembly
made several additions to the Tennessee Code Annotated (Title 63) by enacting the "Medication
Error Reduction Act of 2004 (MERA)". The purpose of this act was to create a standard with
which written and electronic prescription orders must comply, intending to reduce or prevent
medications-related errors l • The new standards set by MERA address several issues of prescription
legibility and include the following:
• Written and electronic orders for a drug must be legibly printed or typed.
• Written and electronic orders for a drug must be signed on the date issued.
• The drug quantity must be written in both letters and numerals.
The aforementioned standards accompany those previously outlined in Title 63, which
dictate that prescriptions must contain the name of the prescriber, the name and strength of the
drug prescribed, instructions for proper use of the drug, and the month and day that the prescription
was issued. Coupled with the new prescription criteria outlined in MERA, these more clearlydefined standards help reduce the potential for phannacist error.
The purpose of MERA- to reduce and prevent medications-related errors- can only be
effective if all medical professionals comply with the law. Because the new legislation amends
several sections of Title 63, the new criteria applies to all medical professionals involved in the
prescription process, including physicians, dentists, optometrists, nurses, and phannacists. Without
proper education and enforcement of the new legislation on all parties involved, the Act can do little
to reduce or prevent medications-related errors. Promoting the overall safety and health of patients
in Tennessee requires the cooperation of authorized prescribers and not simplyphannacists.
The primary function of this research was to evaluate the overall awareness among
phannacists with the Medication Error Reduction Act and prescriber compliance with the new
legislation since its initiation in July of 2004. This was accomplished by two procedures, an on-site
survey of area phannacists, and an observational analysis of prescriptions dated after July 1, 2004.
The purpose of the survey procedure was to assess the level of phannacist awareness and the
perceived levels of noncompliance regarding prescriptions received since July 1,2004. The purpose
of the observational analysis was to quantify the levels of noncompliance beyond phannacist
perceptions by analyzing individual prescriptions. It is expected that the results from these two
procedures will demonstrate the overall effectiveness of the Act in terms of phannacist awareness,
the level of noncompliance among authorized prescribers, and potential avenues for improving
future legislation. Because the Tennessee General Assembly has introduced legislation for the
Spring 2005 session to revise the law, this research is especially significant in highlighting the need
for such revisions.

Methods
I

State of Tennessee General Assembly. PublicA as, Chapter No. 678. May 2004.
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As mentioned previously, this research was composed of two independent procedures, one
that swveyed responses of pharmacists to MERA and its effectiveness, and a second procedure to
quantify prescriptions that do not comply with both the new criteria and those previously outlined in
Title 63.
Procedure 1, Phannacist Survey. The swvey was compiled to address several issues, including
pharmacist awareness, the level of noncompliance among received prescriptions, and potential
methods for further reducing medications-related errors. To detennine these items, the swveywas
composed of the following questions:
1) .Are you aware that the Tennessee state legislature passed the Medication Error Reduction
Act in July 2004, a regulation that defines certain criteria with which medication infonnation
must comply? Resparxlents uere giren the qnim if selecting "Yes"» or "No»; an att:aOxd shret c.mtaimd

a Sumtnlry ifthe legjslatWnfor any respon:Jents selecting "No».

2) Of the prescriptions you have received sine July 1, 2004, what percentage of them do you
feel are fully (100%) compliant with the criteria defined by MERA? Resparxlents uere gf'l£n the

cption ifcJ;wing 0lX! if.foe options, "0-20%». "21-40%», "41-60%», "61-80%» and "81-100%».
3) Of the prescriptions you have received since July 1, 2004, what percentage of them do you
feel are at least partially compliant with the criteria defined by MERA? &Jxnlents uere giw'l

the sam! set ifdxia!s famd in Qiestion 2
4) Of the criteria outlined in MERA, which one do you feel is most often non-compliant?
Resparxlents uere gf'l£n the cption if cJ;wing 0lX! if the fdlauirrg, ansuers: "A. Prescription is na printed
(in either 1'UHJtrSne harrlwiting or from a canputer print-aa) », "B. Prescription is na sigrm, by licensed
prrfessional», "C Nam! ani s~ if mr1icatian is na irKiuded an the prescription», "D. Medication
quarrliry is na witten in bah rrmrbers and /etters», "E. Prescription instruaions are na irKiuded», "P.
Prescription is na dated», or "G Pmcription is na sigrm, an the day iforder. »
5) I feel that the MERA legislation is necessary and will significantly reduce medication errors.

Resparxlents uere gJ'l£n the cptian to cJ;we 0lX! if the f~ "Strurlfiy AgrreJJ, "Agrre", "Neutral",
"Disagree", am "Strrlnfiy Disagree. "
6) What else do you think could be done to prevent or reduce medications errors? &Jxnlents
uere giw'l the qnim to cJ;we all that they felt applied from the fdlauirrg, cptians: "A. Ph)sUians shaJd
in1ude the reasa(s)/irr1icatiat(s) for prescribing, a certain mr1icatian", "E. Ph)sUians ani/or
mmufaaurers shaJd mike a SfXrial iffort to darify samd-alike/la}e-alike nam:s», "C Ph)sUians shaJd
re requim/ to darify abl:nr?datians or ronpletely w7te aft si~. "
7) Would you favor a system where all prescriptions are transmitted electronically? Resparxlents
uere gf'l£n the qnim ifcJ;wing "Yes"» or "No".
After constructing the sUIVey, a directory of 101 retail phannacies (independent and chain)
in the greater Knoxville area was compiled to generate a random sample. Prior to choosing a
random sample, cotporate representatives for the major chain phannacies were contacted for swvey
approval. One major chain opted not to participate, reducing the number of potential phannacies
from 101 to 90. A stratified random sample of 70 pharmacies was then taken from the directory so
that all participating chains would be represented.
On several days in December and January of 2004-2005, on-duty pharmacists at each of the
chosen practice sites were asked to respond to the swveyand were given the option to either
participate in person or to complete the swveyat their convenience. Out of the 70 phannacists
approached for the swvey, 68 (97%, N =68) agreed to participate. Aside from answering the
provided questions, phannacists were also encouraged to add any additional comments regarding the
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research or the MERA legislation in general. The surveys were then collected and all of the data
compiled.
Procedure 2, Prescription Observations. The prescription analysis was performed at a
community phannacy centrally located in East Tennessee, where the majority of prescription orders
are received from both the greater Knoxville and Chattanooga areas. To quantify the levels of
noncompliance among received prescriptions, 500 printed or handwritten prescriptions dated after
July 1, 2004 were pulled randomly in lots of 100. Each prescription was then examined for the
criteria listed in Tide 63, including whether the prescription was printed (in non-cursive handwriting
or type-written), contained all of the necessary information (name of prescriber, name and strength,
quantity, instructions for proper use, date, and signature on the date issued), and had the drug
quantity written in both letters and numerals. Additionally, of those quantities not written in letters
and numerals, the number of controlled substances was also noted. Each item of noncompliance
was then recorded and compiled.

Results
Phannacist Survey
Table 1 contains survey responses to question 1, which assessed the overall awareness of the
Medication Error Reduction Act among Table 1. Awareness
pharmacists. As illustrated in the table, 71% of Are you aware that the Tennessee state legislature passed
the pharmacists surveyed responded that they the Medication Error Reduction Act in July 2004, a
were aware of the MERA legislation, while 29% regulation that defines certain criteria with which
were not. Because the remainder of the survey medication information must comply?
Score
depended on information found in the Act, Response
respondents who were unfamiliar with its Yes
71%
29%
contents were supplied with a short summary No
describing the new legislation.
Table 2 contains data from survey questions 2 and 3, which sought to identify the percentage
of prescriptions that pharmacists felt were fully or partially compliant with the new criteria found in
the MERA legislation. The table shows
Table 2. Perceived Levels of Compliance
that 17.6% of pharmacists felt that
Percentage
Score
Level of Compliance
between 0- 20% of received prescriptions
Compliant
were
fully compliant with the MERA
Full Compliance. Of the
0-20%
17.6%
legislation. Likewise, 25.0% felt that 21prescriptions you have received
21-40%
25.0%
40% of received prescriptions were fully
since July 1, 2004, what percentage 41-60%
22.1 %
of them do you feel are fully
compliant with the new legislation.
61-80%
23.5 %
(100%) compliant with the criteria
Further
details can be seen in the table.
81-100%
11.8 %
defined by MERA?
The bottom portion of Table 2
Partial Compliance. Of the
prescriptions you have received
since July 1, 2004, what percentage
of them do you feel are at least
partially compliant with the criteria
defined by MERA?

describes the percentage of prescriptions
that pharmacists felt were at least partially
compliant with the new criteria. As
shown in the table, 22.1% of the
pharmacists surveyed felt that 41-60% of
the prescriptions they had received since
.
July 1, 2004 were at least partially
comp~t and 27.9% felt that 61-8?%. of prescriptions were partially compliant. 44.1% of the
pharmacISts surveyed felt that the maJonty (81-100%) of received prescriptions were at least partially
compliant with the new legislation.
0-20%
21-40%
41-60%
61-80%
81-100%

1.5 %
4.4 %
22.1 %
27.9%
44.1 %
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Table 4

Table 3
Of the criteria outlined in MERA, which one do you feel is most often

non-compliant?

Response
Rx is not printed (non-cursive handwriting or typewritten)
Rx is not signed by a licensed professional
Name and strength of medication is not included on Rx

Quantity is not written in letters and numerals
Rx instructions are not included

Rx is not dated
Rx is not signed on the day of order

Score
41.2 %
4.4 %
5.9%
45.6%
0%
2.9%
0%

Pharmacist Response to the necessity
and significance of MERA legislation.

Response
Strongly Agree
Agree
Neutral
Disagree
Strongly Disagree

Score
51.5 %
33.8%
13.2%
1.5 %
0%

The criteria which phannacists felt were the most often noncompliant can be found in Table
3. The data here contains the new items outlined in MERA as well as those previously found in
Title 63. The table illustrates that most phannacists felt that the two criteria most often
noncompliant are that the prescription is either not printed (41.2%) or that the medication quantity
is not written in both letters and numerals. Other significant criteria included that the prescription
was not signed by a licensed professional (4.4%), not dated (2.9%), or that it does not include both
the name and strength of the medication (5.9%).
Table 4 describes the overall reaction of phannacists to the Medication Error Reduction Act.
More specifically, it illustrates whether phannacists feel the MERA legislation is necessary and will
significantly reduce medications-related errors. Over half of the respondents (51.5%) strongly
agreed that the Act was necessary and will significantly reduce errors. Another 33.8% of
phannacists agreed that the law is necessary, while only 13.2% were neutral and 1.5% disagreed,
believing that the Act would not significantly reduce medications errors.
In Question 6, three choices were presented as potential means for the further reduction or
prevention of medication errors. Table 5
Table 5 illustrates these results. What else do you think could be done to prevent or reduce medications
Because respondents could choose errors?
all that apply, the sum of the Response
Score*
percentages do not equal 100%. Physicians should include the reason(s)/indication(s) for
80.8%
.As the table indicates, 80.8% of prescribing a certain medication.
the phannacists surveyed felt that Physicians and! or manufacturers should make a special
47.1 %
including
the
reasons
or effort to clarifysound-a1ike/look-a1ike names.
indications for medications would
should be required to clarify abbreviations or
60.3 %
aid in preventing or reducing Physicians
completely write out sigs.
medications-related
errors.
Another significant percentage * Respanlents cmld ~e all that applie1; the sum ifthese perrentags das m
(60.3%) felt that physicians should 81ua{100%
be required to clarify abbreviations
or completely write out sigs. Finally, a smaller percentage (47.1%) of respondents felt that clarifying
sound-alike or look-alike names would significantly prevent or reduce medications errors.
Finally, the last question of the survey assessed
Table 6
whether phannacists would favor a system in which all
Would you favor a system where all
prescriptions are transmitted
prescriptions were transmitted electronically. The results of
electronically?
this data are included in Table 6. Over three-quarters
Response
Score
(75%) of the respondents stated that they would favor a
Yes
75%
system where all prescriptions were transmitted
No
25%
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electronically, whereas the remaining 25% would not favor such a system.
Prescription Observations
To quantify the relative level of noncompliance with MERA, 500 prescriptions dated after
July 1,2004 were pulled from file and analyzed for the criteria outlined in the new legislation as well
as that previously found in Title 63. To qualify for this analysis, the prescriptions had to be
handwritten or printed (either from the physician's office or via fax); call-in prescriptions were not
considered. The prescriptions were drawn in lots of 100 from a random five business days. Each
prescription was then analyzed individually and noncompliant criteria were recorded. Table 7 lists
the results from these observations.
Because a number of the prescriptions analyzed were noncompliant with multiple criteria,
the sum of the percentages here does not equal 100%. As shown in the table, 56.8% of the
prescriptions observed were not printed (in non-cursive handwriting or from a computer print-out).
10.4% of the prescriptions did not contain the name of the prescriber. Note that prescriptions were
scored for this criterion if either:
Table 7
1) The prescription was not signed, or
Prescription Observations
2) The prescription was a hospital or
Score (n=500)
Criteria
institution blank and included no
Rx
was
not
printed
56.8%
additional means of identification
Name of prescriber not included*
10.4%
other than a signature.
Name
and
strength
of
drug
not
included
6.2%
6.2% of the prescriptions did
Quantity not written in letters and
70.8%
not have the name and strength of the
numerals
drug included. By far, the most
(0Jntrdlad substam5)
15.2%
noncompliant criterion was that the
Proper
instructions
not
included
2%
medication quantity was not written in
Rx
was
not
dated
2.6%
both letters and numerals, with 70.8%
Rx
was
not
signed
on
the
date
issued
3%
of the observed prescriptions being
*
"Nanr
if
presC7'ikr
rKX
in:iu:le:l"
r{enrrl
/;ah
txJ
tlne
prescriptions 7.iherr!
noncompliant.
More importantly,
the presC7'ikr did n:t: sign the presoiptian or in the case 7.iherr! the prescription
15.2% of the total prescriptions were
W1S a hapital or institution liank ani only a sif!.nature W1S iniz&d
written for controlled substances and
did not have the quantity written in
both letters and numerals. The final three criteria listed in the table were that proper instructions
were not included, the prescription was not dated, and that the prescription was not signed on the
date issued, with scores of 2%, 2.6%, and 3%, respectively.
Figures 1-4 illustrate actual prescriptions analyzed in this study. To comply with I-llPAA
regulations and to protect identities of the prescribers, all identifiable information has been blurred
out or removed altogether.

Discussion
The pwpose of the survey was to evaluate the overall awareness of the Medication Error
~~uction Act am<:>~ pharmacists ~d its perceived effectiveness. The results of the survey clearly
mdicate that a maJonty of pharmacISts (almost three-fourths) were familiar with the Act and its
contents. r:o:vever, becaus~ they require. verificatio? ~d approval f;om the authorized prescriber
?efore ~odifying or ~orrectmg ~oncompliant p~scnpt1ons, pharmacISts have relatively little power
m assunng the compliance of wntten or electroruc prescriptions.
. When a question regarding the accuracy or validity of a prescription arises, the pharmacist is
reqUIred by law to contact the authorized prescriber for verification prior to dispensing the
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medication. The pharmacist may then be faced with trying to contact the prescriber through a
receptionist or nurse, which as several respondents noted, often results in an extended game of
"phone tag." Though the law allows the pharmacist to delay dispensing the prescription until
verification is made, it does nothing to alleviate the dilemma of having to tell a waiting customer that
verification from the prescriber is needed and may take anywhere from a few minutes to several
hours to receive.
Despite the new standards set by MERA, phannacists believed that the new legislation
would do little to reduce medications-related errors if it was not being effectively enforced. This was
further evidenced by their responses to questions 2 and 3, which sought to evaluate how many
prescriptions they perceived were being fully or partially compliant with the new criteria. As was
seen in the results, 25% of the respondents believed that only 21-40% of the prescriptions they had
received were fully compliant with the new criteria. Also significant was the fact that 22.1% believed
that 41-60% of received prescriptions were compliant. Although 23.5% believed that 61-80% were
fully compliant with MERA, many conunented that this number is still far below the number of
prescriptions that shadd be fully compliant.
Several pharmacists also noted that the types of prescriptions they received often influenced
the perceived levels of compliance. .At some practice sites, the majority of prescriptions carne from
electronic orders, where the levels of noncompliance are generally low. Other pharmacies, however,
which receive the majority of their prescriptions as handwritten orders, reported a higher number of
noncompliant prescriptions.
The criteria that survey respondents felt were most often noncompliant was that the
prescriptions were either not printed (in non-cursive handwriting or from a computer print-out) or
that they did not have the quantity written in letters and numerals. As will be described later, these
perceptions were consistent with independent observations of actual prescriptions. Many of the
respondents conunented that it was difficult to simply choose one of the options listed on the
survey. Again, this was also consistent with prescription analysis, as many contained multiple
violations.
Despite not being effectively enforced, the majority of pharmacists believed that this t}pe of
legislation is necessary and, if enforced, would reduce medications-related errors. To make the
legislation more effective, however, respondents indicated that including the indications for
prescribing certain medications and completely writing out abbreviations would further prevent or
reduce medications errors. A smaller percentage felt that physicians and manufacturers should make
a special effort to clarify sound-alike and look-alike names, but that this t}pe of modification would
be unnecessary if prescriptions were already compliant with the other criteria. In addition, several
respondents also noted that many manufacturers already make a special effort to clarify sound-alike
and look-alike names, such as distinguishing between hydr-OXY-zine and hydr-ALA-zine.
The final question in the survey assessed whether pharmacists would favor an all-electronic
transmission system as a potential means for reducing or preventing medications- related errors.
Three-fourths of the pharmacists surveyed indicated that they would favor a system where all
prescriptions were transmitted electronically. Several pharmacists responded that this would not
only reduce and prevent medications-related errors- it would also help to reduce the number of
potential forgeries. An electronic system reduces errors by transmitting prescriptions that are
completely legible and, as will be discussed later, it also eliminates the need for receptionists to call in
prescriptions.
Though a majority of pharmacists favored an all-electronic prescription system, some had
reservations. One issue raised was that, although there are a reduced number of errors, some have
been known to occur in physicians offices which utilize electronic devices (such as PDAs) to

BR8

transmit prescnptlons. Physicians may unknowingly choose the wrong strength or quantity simply
by a misplaced pen stroke.
Several respondents also had concerns with all prescriptions being transmitted electronically,
citing that certain medications, such as controlled substances, should still be transmitted by
traditional means. Additionally, a few noted that an all-electronic system would be a prime target for
abuse or manipulation by highly-skilled personnel. Such a system would require high levels of
encryption as well as safeguards to prevent abuse. A final concern expressed by several of the
respondents was the cost of implementing an electronic transmission system, an issue expected to be
considerably more significant for independent and smaller community pharmacies.
Following the survey, respondents were
WI'
given the opportunity to ask questions or give
m
&t
'7
=
any additional comments regarding this research
or the Medication Error Reduction Act itself.
One pharmacist noted another potential source
of
error
which
may
result
from
miscommunication between the physician and
pharmacy through non-licensed personnel, such
as receptionists and medical assistants. She
noted that pharmacists, authorized prescribers,
and pharmacy technicians are licensed or
registered by the State of Tennessee. However,
Df.A:_
non-licensed personnel may be just as involved
in the transfer of medical information between
Fig 1. Prescription legibility
the physician and the pharmacy, but are not
Is the smnl mr1ication here Olexa 20ng or O/ebrex 200rrg?
currently required to have any type of formal
education. Other pharmacists confirmed this
observation, noting specific instances where
receptionists were unable to pronounce certain
medications or were asked to spell out generic
FOR , •.. ---------.:!.!L--~ . "
.................
prescription orders to the pharmacist over the
II
~. ;;" . . . J.l ! <
. ry" .
'J '1 ~0,,ADDREJ;S:. ...•...~.-"" _
•.z ~.~.. DATJ... _. '''
...
telephone.
observational
analysis
of
The
B
I
prescriptions pennitted an actual quantification
rff.., -, A~ Pf1
of noncompliant criteria, confinning the
f'~
perceptions found in the pharmacist survey. As
INIH,I"
was seen in the survey responses, the two most
Rctill_-=r... _ Times
noncompliant
criteria
were
that
the
MD
M.O.
prescriptions were not printed (in non-cursive
Fig 2. Legibility of controlled substances
handwriting or from a print-out) or that they
This mr1ication 'WIS first rristakenfor L artab, but 'WIS later a:JrYIrt8:i did not have the medication quantity written in
to Lam:til, after the last 'lIlJ1'd 'WIS deterrrimJ as ~ "dianhea»;
letters and numerals. Moreover, 15.2% of the
Phyician 'WIS aJI1J:aCt8ifor wifoati.on.
medications noncompliant with this criterion
were controlled substances, where the
likelihood of forgery is typically higher. It can be reasonably inferred that requiring medication
quantities to be written in letters and numerals is an effort to reduce the prevalence of forgery and
abuse of controlled substances. However, when prescribers fail to put this component of the
MERA legislation into practice, the effort to reduce forgery is thus cancelled out.

I

g- ~\Uilc., ~
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Prescriptions that either did not have
<~nm
the signature of the prescribing physician or "ffi =w ¥hi
were simply a clinical blank and contained only :w
the signature of the prescriber (and not a
711312004
printed version of the name indicated elsewhere
Rlf.:
on the prescription) were scored as not
Dilantin
including the "name" of the prescribing
loomgcap
Dispense: 93 (ninety-tIlTCC:)
physician. Larger institutions, such as medical
label:
centers and hospitals have a number of
Tate I (one) cap PO 3 (thrcc:) tim« daily,
physicians on-duty at any particular time, many
for seizure disorder"
of which use the same blanks. As a result,
Refill.:
verifications on prescriptions may be difficult to
1 (one)
obtain.
Many prescriber signatures are
unintelligible at best and make it virtually
~"
Uispense as written
impossible to contact the physician if Mlly !lu?s!.\lWII ."
verification of a prescription is required. Simply Fig 3. Use of computer-generated prescriptions
requiring that a prescriber print his or her name The abar.e imt~ dem:mstrates the ad:u:mta~ ifa amputeriz£d S)5tem
along with the signature would easily eliminate 7Jhere ME RA criteria arefolji1k1 autarntimJJy.
this problem
The results of the observational analysis
also illustrated that over 50% of the prescriptions were not written in non-cursive handwriting or
were not from a computer print-out. Writing a prescription in cursive automatically introduces the
potential for error, as pharmacists must interpret even the most subtle pen stroke. Physician
handwriting has always been the subject of tongue-in-cheek humor, even being highlighted in "Can
You Read These Rxs?", a feature in every issue of
the NO:>A's Pharmuy Tim:s. As examples of the
problems associated with legibility issues, actual
Zft"
prescriptions from this analysis can be viewed in
Figures
1 and 2, showing the need for this type of
NAME
rr
"AGE
legislation.
Figure 3 illustrates the advantage of
DKn: I\~\Q::>
ADDRESS ___
using a computer-generated print-out for
\<eC1~ SoD4
prescriptions. Handwritten prescriptions, as seen in
.t.~ (~~e,\q'"'t)
Figure 4, can also comply with all of the regulations
~ ~ll.k> ~o ~i.a. "14d0.4S
outlined in the new legislation. Humor aside,
a LABEL
prescriber handwriting can be a serious issue as a
~34PRN
simple misinterpretation of a prescription may lead
;UBSTJTUTI"A-LL-OWE-,D"~m DlPl£NSI!ASWRflTI£N ,M"ll" to a potentially disastrous medication error. In
Fig 4. Handwritten compliant prescription
other words, the life of the patient may be at
The abar.e fig;qe dem:mstrates a harr1witten jJrfScription
stake- writing legibly seems hardly the sacrifice to
a:npliant Wth the mocriteria.
simply ensure the health and safety of the patient.
t

.
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"
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Conclusion
Overall, the phannacists sUIVeyed in this research believed that the MERA legislation is
necessary, but in order to be completely effective, it should be enforced on authorized prescribers as
well. After all, pharmacists are only a piece of the "error puzzle" - the responsibility of reducing
and preventing medications-related errors should be shared by the prescribers who write
prescription orders and the phannacists who dispense them. As a result, the Medication Error
Reduction Act could readily accomplish its goal of reducing or preventing medications errors if
properly enforced by the appropriate government entities.
As this research has shown, a majority of phannacists are well aware of the new legislation;
additionally, nearly all of the pharmacists sUIVeyed agreed that such legislation is necessary.
However, the law grants pharmacists little power in modifying or correcting noncompliant
prescriptions, because approval by the authorized prescriber is required. As described above,
contacting the authorized prescriber almost always involves a considerable delay in dispensing a
prescription. In many cases, the one or two hours a customer is required to wait is one or two hours
too many. Most importandy, this delay may be completely unnecessary- if its provisions are
followed correcdy, the Medication Error Reduction Act gready reduces the possibility of delaying a
prescription, especially if the verification is to simply clarify an ambiguous or illegible word.
Therefore, this research demonstrates the need for revising the Medication Error Reduction
Act, as proposed by the General Assembly for the Spring 2005 session. Because pharmacists cannot
prescribe medications and their ability to modify prescriptions is subject to the approval of the
authorized prescriber, their responsibilities to ensure compliance with the MERA legislation can
only go so far- prescribers and phannacists together must share the responsibility of reducing and
preventing medications-related error. It is evident that legislation such as MERA is a step in the
right direction to promote better health for Tennessee residents; however, as seen in this research,
the law is only effective if Tennessee prescribers are also enforced to comply. So far, the Board of
Pharmacy has taken the steps necessary to enforce the law on Tennessee pharmacists, but is
powerless if prescribers are not held to this same standard. It is time for Tennessee prescribersphysicians, dentists, optometrists, and other professionals alike- to be held to that same standard.

